A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
Salicylamide has been studied across 13 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, 💊 Pain, 🦠 Gut & Microbiome, 😴 Sleep. The primary research focus is 🫁 Liver & Detox with 9% of studies addressing this area.
This evidence profile for Salicylamide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.